Literature DB >> 32362029

Neurodevelopmental impairment at 3 years of age after fetoscopic laser surgery for twin-to-twin transfusion syndrome.

Sachio Matsushima1, Katsusuke Ozawa1, Rika Sugibayashi1, Kohei Ogawa2, Keiko Tsukamoto3, Osamu Miyazaki4, Seiji Wada1, Yushi Ito2, Haruhiko Sago1,2,3.   

Abstract

BACKGROUND: Data on neurodevelopmental outcomes of children surviving after fetoscopic laser surgery (FLS) for twin-to-twin transfusion syndrome (TTTS) are scarce.
METHODS: We retrospectively investigated children surviving after FLS for TTTS at 16 to 26 weeks' gestation between 2003 and 2014. Children were evaluated by standardized neurologic examinations using the Kyoto Scale 2001 at a corrected age of 3 years ± 6 months. Neurodevelopmental impairment (NDI) was defined as cerebral palsy (CP), bilateral blindness, bilateral deafness or a developmental quotient (DQ) < 70 points. Brain magnetic resonance imaging (MRI) was performed at term-equivalent age.
RESULTS: A total of 188 children from 110 twin pregnancies were evaluated. NDI was detected in 16/188 (8.5%) children, including six cases of CP (3.2%). No children had bilateral blindness or deafness. An earlier gestational age at delivery was associated with a higher incidence of NDI (P < .001). Abnormal brain MRI findings were detected in 9/16 (56%) of children with NDI, including 6/6 (100%) with CP.
CONCLUSION: The incidence of NDI in children following FLS at 3 years old was 8.5%. Prematurity is a strong risk factor for NDI. Brain MRI may predict the development of CP.
© 2020 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Year:  2020        PMID: 32362029     DOI: 10.1002/pd.5726

Source DB:  PubMed          Journal:  Prenat Diagn        ISSN: 0197-3851            Impact factor:   3.050


  3 in total

1.  Long-term neurodevelopmental outcomes of the pump twin in twin reversed arterial perfusion sequence treated by radiofrequency ablation.

Authors:  Katsusuke Ozawa; Seiji Wada; Jin Muromoto; Rika Sugibayashi; Yuka Sano Wada; Yushi Ito; Haruhiko Sago
Journal:  Prenat Diagn       Date:  2021-09-25       Impact factor: 3.242

2.  Controlled amnioreduction for twin-to-twin transfusion syndrome.

Authors:  Zoya Gordon; Aviva Fattal-Valevski; David Elad; Ariel J Jaffa
Journal:  Ther Adv Reprod Health       Date:  2022-03-29

3.  New challenges of fetal therapy in Japan.

Authors:  Seiji Wada; Katsusuke Ozawa; Haruhiko Sago
Journal:  J Obstet Gynaecol Res       Date:  2022-06-08       Impact factor: 1.697

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.